sarepta arrowhead news - Search News

Arrowhead climbs

BioPharma Dive · 11h

Sarepta rebuilds drug pipeline with Arrowhead deal

A broad licensing and research alliance will hand Sarepta four clinical-stage candidates, while Arrowhead receives $500 million in cash and another $325 million in equity.

Seeking Alpha · 1d

Arrowhead climbs after licensing deal with Sarepta

Arrowhead Pharmaceuticals (ARWR) stock surges 21% in premarket after $825M licensing deal with Sarepta (SRPT) for rare genetic disease treatments. Read more here.

YAHOO!Finance · 15h

Sarepta to pay Arrowhead $500M + in licensing deal for siRNA-based treatments

Sarepta Therapeutics (SRPT), the leader in precision genetic medicine for rare diseases announced an exclusive global licensing and collaboration agreement with Arrowhead (ARWR) Pharmaceuticals ( ARWR).

8h

Arrowhead: The Sarepta Partnership Validates RNAi Platform And Reduces Risk

Arrowhead Pharmaceuticals' stock rallied 17% due to significant pipeline developments and strategic partnerships. Learn more ...

Stocktwits on MSN8h

Arrowhead, Sarepta Stocks Rise Despite Price-Target Cuts Post $1B Licensing Deal: Retail Buzz Strong

($ARWR) and Sarepta Therapeutics Inc. ($SRPT) climbed on Wednesday despite Wall Street trimming price targets after the ...

FierceBiotech1d

Sarepta pays $500M cash for rights to 'multiple potential blockbusters' from Arrowhead

Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for ...

GlobalData on MSN18h

Arrowhead and Sarepta link for rare genetic disease treatments

Arrowhead Pharmaceuticals has entered a worldwide licensing and partnership agreement with Sarepta Therapeutics to develop ...

Sarepta, Arrowhead Pharmaceuticals partner to advance RNA-based drugs in rare diseases

Sarepta Therapeutics said it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based ...

1d

Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On?

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) shares are trading higher Tuesday after the company announced a global ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results